Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
- Type
- Retraction
- Notice date
- 2/2/2021 0:00
- Journal
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Notice DOI
- 10.1039/d1ra90067f
- Original paper DOI
- 10.1039/c8ra00296g
Reasons
- Duplication of/in Image
- Falsification/Fabrication of Image
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Unreliable Results and/or Conclusions